raymond xu
senior director, clinical pharmacology at apellis pharmaceuticals
biotechnology, health
boston, massachusetts, united states
mark zayec
corporate account director
Contact Information
Professional Email
****@****.com
Personal Email
mza****@gmail.com
Work Phone
(***) ***-***
Mobile
(***) ***-***
Local Location
holland, new york, united states
HQ Location
waltham, massachusetts, united states
Industry
biotechnology,
Designation
corporate account director
Birthday
-
Gender
male
At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system. Our work is rooted centrally at C3, which is the only target in the complement cascade that addresses all three pathways that can drive disease. Targeting C3 has broad platform potential to treat many diseases where patients have few or no treatment options available. Our programs across ophthalmology, nephrology, hematology, and neurology are further exploring what is possible by targeting C3. You can view our community guidelines here: Community guidelines: http://bit.ly/476Q8
HQ Location
waltham, massachusetts, united states
Industry
biotechnology research
Employees
769
Founded
2008
Get Contact Detail in 3 Steps
1
Install Chrome Extension for Free
Install the Orion chrome extension from the Web Store. Sign up using your email address.
2
Access Profile Information
The Extension will sync with your LinkedIn from where you can discover in-depth Prospects' profiles, company information and Find Similar details.
3
Get In-Depth Contact Details
Get detailed insights of Prospects Company Profile, Email ID, Phone Number, Location or Similar Designation and much more.